Genprex, Inc.股价拉升12.82% 市值涨58.55万美元

市场透视2025-02-13

北京时间2025年02月13日22时31分，Genprex, Inc.（GNPX.us）股票出现异动，股价大幅拉升12.82%。截至发稿，该股报0.537美元/股，成交量766.14万股，换手率90.05%，振幅1.64%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.32百万美元，每股收益-1.23美元，毛利-1272.00美元，市盈率-0.05倍。机构评级方面，在所有1家参与...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2511851526?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-13 22:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2511851526","market":"us","top_or_hot":-1,"title":"Genprex, Inc.股价拉升12.82% 市值涨58.55万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年02月13日22时31分，Genprex, Inc.（GNPX.us）股票出现异动，股价大幅拉升12.82%。截至发稿，该股报0.537美元/股，成交量766.14万股，换手率90.05%，振幅1.64%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.32百万美元，每股收益-1.23美元，毛利-1272.00美元，市盈率-0.05倍。机构评级方面，在所有1家参与...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223108abcdb1e3&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genprex, Inc.股价拉升12.82% 市值涨58.55万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenprex, Inc.股价拉升12.82% 市值涨58.55万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-13 22:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223108abcdb1e3&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年02月13日22时31分，Genprex, Inc.（GNPX.us）股票出现异动，股价大幅拉升12.82%。截至发稿，该股报0.537美元/股，成交量766.14万股，换手率90.05%，振幅1.64%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.32百万美元，每股收益-1.23美元，毛利-1272.00美元，市盈率-0.05倍。机构评级方面，在所有1家参与...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223108abcdb1e3&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223108abcdb1e3&s=b","article_id":"2511851526","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223108abcdb1e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2511851526","pubTimestamp":1739457068,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年02月13日22时31分，Genprex, Inc.股票出现异动，股价大幅拉升12.82%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为970.17%、765.03%、89.78%，振幅较大的相关个股有Enliven Therapeutics, Inc.、Rezolute, Inc.、Edesa Biotech, Inc.，振幅分别为7.80%、4.53%、4.03%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","GNPX":"Genprex, Inc."},"translate_title":"Genprex, Inc. 's stock price rose 12.82% and its market value rose by $585,500","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GNPX":1},"content_text":"北京时间2025年02月13日22时31分，Genprex, Inc.（GNPX.us）股票出现异动，股价大幅拉升12.82%。截至发稿，该股报0.537美元/股，成交量766.14万股，换手率90.05%，振幅1.64%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.32百万美元，每股收益-1.23美元，毛利-1272.00美元，市盈率-0.05倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm (Holdings) Plc C/Wts 10/02/2028 (To Pur Ads)涨幅较大，Tc Biopharm (Holdings) Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为970.17%、765.03%、89.78%，振幅较大的相关个股有Enliven Therapeutics, Inc.、Rezolute, Inc.、Edesa Biotech, Inc.，振幅分别为7.80%、4.53%、4.03%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。其技术旨在输送抗疾病基因，为目前治疗选择有限的大量癌症和糖尿病患者提供新疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。该公司的主力产品候选药物Reqorsa免疫基因疗法（quaratusugene ozeplasmid）正在三项临床试验中评估其作为NSCLC和SCLC治疗的疗效。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2511851526","isCrawlerRequest":true}